The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors
Molecular Cancer Therapeutics (2010) - Comments
pubmed: 20889731  doi: 10.1158/1535-7163.mct-10-0539  issn: 1538-8514  issn: 1535-7163 

Deborah Castelletti, Giulio Fiaschetti, Valeria Di Dato, Urs Ziegler, Candy Kumps, Katleen De Preter, Massimo Zollo, Frank Speleman, Tarek Shalaby, Daniela De Martino, Thorsten Berg, Angelika Eggert, Alexandre Arcaro, Michael A. Grotzer